Best Practices for Annotated CRFs
In this webinar, Amy Garrett reviews published guidance from regulatory agencies and provides best practices…
CertaraJuly 30, 2020
Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm
Drug development in oncology commonly exploits the tools of molecular biology to gain therapeutic benefit…
CertaraJuly 26, 2020
Model‐Informed Drug Repurposing: Viral Kinetic Modeling to Prioritize Rational Drug Combinations for COVID‐19
We hypothesized that viral kinetic modeling could be helpful to prioritize rational drug combinations for…
CertaraJuly 26, 2020
Salvaging CNS Clinical Trials Halted Due to COVID‐19
The coronavirus disease 2019 (COVID‐19) pandemic has halted many ongoing central nervous system (CNS) clinical…
CertaraJuly 15, 2020
The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development
3 key tips to set your pediatric program up for success with the RACE for…
CertaraJuly 14, 2020
Mechanistic quantitative pharmacology strategies for the early clinical development of bispecific antibodies in oncology
Bispecific antibodies (bsAbs) have become an integral component of the therapeutic research strategy to treat…
CertaraJuly 14, 2020
Understanding the Duplicate Records Validation Rules
In this blog, we clarify the meaning & purpose of the duplicate records validation rules,…
CertaraJuly 7, 2020
The supplementary domain in SDTM: good, bad and ugly
All you need to know about the supplementary domain in SDTM The supplementary domain in…
CertaraJuly 2, 2020
